Bills · H.R. 10919 · Text

Introduced in House

Confirmed from the official record

Our copy of the file on govinfo.gov, saved November 13, 2026. Fingerprint (SHA-256): 41996787e463ce63.

H.R. 10919: the bill

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10919 Introduced in House (IH)]

<DOC>






119th CONGRESS
  2d Session
                               H. R. 10919

  To amend title III of the Public Health Service Act to ensure that 
certain safety net providers are not required to pay more than the 340B 
  ceiling price for covered outpatient drugs at the time of purchase.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            October 29, 2026

 Mr. Bergman (for himself, Mr. Ruiz, Mr. Cleaver, Mr. Mann, Ms. Titus, 
Ms. Norton, Ms. Davids of Kansas, Ms. Balint, Mr. Golden of Maine, Mr. 
Moulton, Mr. Hernandez, Ms. Stansbury, Mr. Austin Scott of Georgia, and 
Mr. Newhouse) introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
  To amend title III of the Public Health Service Act to ensure that 
certain safety net providers are not required to pay more than the 340B 
  ceiling price for covered outpatient drugs at the time of purchase.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Safety Net Provider Drug Pricing 
Protection Act''.

SEC. 2. ENSURING UPFRONT 340B DISCOUNTED PRICING FOR CERTAIN SAFETY NET 
              PROVIDERS.

    (a) In General.--Section 340B(a) of the Public Health Service Act 
(42 U.S.C. 256b(a)) is amended by adding at the end the following new 
paragraph:
            ``(11) Upfront discounted pricing for certain safety net 
        providers.--
                    ``(A) In general.--The Secretary may not enter into 
                an agreement with a manufacturer of covered outpatient 
                drugs under paragraph (1) under which the amount 
                required to be paid to the manufacturer for covered 
                outpatient drugs by a safety net covered entity 
                exceeds, at the point of purchase of such drug, the 
                applicable ceiling price for such drug (as described in 
                paragraph (1)).
                    ``(B) Safety net covered entity.--For purposes of 
                subparagraph (A), the term `safety net covered entity' 
                means a covered entity that--
                            ``(i) is described in any of subparagraphs 
                        (A), (D), (F), (G), (H), (I), (J), or (N) of 
                        paragraph (4);
                            ``(ii) is an entity described in 
                        subparagraph (K) of such paragraph that 
                        receives funds directly from a State or unit of 
                        local government; or
                            ``(iii) is a sole community hospital 
                        described in subparagraph (O) of such 
                        paragraph.''.
    (b) Rule of Construction.--Nothing in this section, or the 
amendment made by this section, shall be construed to permit under 
paragraph (1) of section 340B(a) of the Public Health Service Act (42 
U.S.C. 256b(a)) any arrangement under which a safety net covered entity 
(as defined in paragraph (11)(B) of such section) pays to the 
manufacturer of a covered outpatient drug an amount in excess of the 
applicable ceiling price for such drug (as described in such paragraph 
(1)) at the time of purchase, with later reconciliation by rebate, 
reimbursement, or other payment.
    (c) Effective Dates.--
            (1) In general.--The amendments made by this section shall 
        take effect on the date of the enactment of this section and 
        shall apply to drugs purchased on or after the date of the 
        enactment of this section.
            (2) Application to existing agreements.--Beginning on the 
        date of the enactment of this section, the amendments made by 
        this section shall be taken into account in determining whether 
        an agreement with a manufacturer of covered outpatient drugs 
        meets the requirements of section 340B(a) of the Public Health 
        Service Act (42 U.S.C. 256b(a)).
                                 <all>
Suggest a tool

Suggest a tool

A person reads each idea before it appears. Links are not accepted. Do not include personal information.

See all ideas and vote